Intranasal lentiviral vector-mediated antibody delivery confers reduction of SARS-CoV-2 infection in elderly and immunocompromised mice

Intranasal lentiviral vector-mediated antibody delivery confers reduction of SARS-CoV-2 infection in elderly and immunocompromised mice

Vaccines for COVID-19 are now a crucial public health need, but the degree of protection provided by conventional vaccinations for individuals with compromised immune systems is unclear. The use of viral vectors to express neutralizing monoclonal antibodies (mAbs) in the lung is an alternative appro...

Full description

Bibliographic Details
Main Authors:	Du, Y, Zhang, S, Zhang, Z, Miah, KM, Wei, P, Zhang, L, Zhu, Y, Li, Z, Ye, F, Gill, DR, Hyde, SC, Wang, Y, Zhao, J
Format:	Journal article
Language:	English
Published:	Frontiers Media 2022

Similar Items

Intranasal Lentiviral Vector-Mediated Antibody Delivery Confers Reduction of SARS-CoV-2 Infection in Elderly and Immunocompromised Mice
by: Yue Du, et al.
Published: (2022-04-01)

Rapid determination of rSIV.F/HN lentiviral vector titre
by: Conway, CC, et al.
Published: (2020)

Lentiviral-mediated expression of monoclonal antibodies in the lung to protect against influenza
by: Du, Y, et al.
Published: (2020)

Lung-targeting lentiviral vector for passive immunisation against influenza
by: Tan, TK, et al.
Published: (2020)

Lung directed antibody gene transfer confers protection against SARS-CoV-2 infection
by: Yue, D, et al.
Published: (2022)

Lung-targeted lentiviral vector mediates passive immunisation against influenza
by: Tan, T, et al.
Published: (2018)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
by: Munday, RJ, et al.
Published: (2020)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
by: Munday, RJ, et al.
Published: (2022)

Cholesterol as an enhancer of lentiviral vector production in serum-free transient transfection
by: Gelinas, J, et al.
Published: (2013)

An Improved Protocol for the Production of Lentiviral Vectors
by: Logan Y. Brown, et al.
Published: (2020-12-01)

Assessment of selected media supplements to improve F/HN lentiviral vector production yields
by: Gélinas, J, et al.
Published: (2017)

Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza
by: Zuleika Michelini, et al.
Published: (2020-12-01)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
by: Munday, RJ, et al.
Published: (2022)

Large-scale, high-throughput production of lentiviral vectors for multiple disease applications
by: Ashworth, R, et al.
Published: (2018)

Lentiviral Vector Bioprocessing
by: Christopher Perry, et al.
Published: (2021-02-01)

Production of lentiviral vectors
by: Otto-Wilhelm Merten, et al.
Published: (2016-01-01)

Advances of Lentiviral Vectors
by: Fanrong MENG, et al.
Published: (2014-12-01)

A method for assessing the distribution of eGFP expressing cells in the mouse lung following lentiviral vector transduction
by: Munday, R, et al.
Published: (2018)

High levels of native eGFP detected following F/HN lentiviral vector transduction of a variety of lung models
by: Munday, R, et al.
Published: (2019)

Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment
by: Sinadinos, A, et al.
Published: (2021)

The very stable lentiviral vector
by: Gwendolyn K. Binder, et al.
Published: (2024-03-01)

Special Issue “Lentiviral Vectors”
by: Yasuhiro Takeuchi
Published: (2022-07-01)

The Inside Out of Lentiviral Vectors
by: Stéphanie Durand, et al.
Published: (2011-02-01)

Effective gene therapy with nonintegrating lentiviral vectors.
by: Yáñez-Muñoz, R, et al.
Published: (2006)

Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies.
by: Sabrina Kneissl, et al.
Published: (2012-01-01)

Improved SARS-CoV-2 Spike Glycoproteins for Pseudotyping Lentiviral Vectors
by: Paul G. Ayoub, et al.
Published: (2021-11-01)

Investigating pseudotyped lentiviral vectors for gene delivery to the lung
by: Munday, RJ
Published: (2021)

Large-scale, high-throughput production of rSIV.F/HN vectors
by: Viegas, MFA, et al.
Published: (2020)

Enhanced lentiviral production through rational design of mammalian host cells
by: Hyde, S, et al.
Published: (2016)

Lentiviral Vectors for Ocular Gene Therapy
by: Yvan Arsenijevic, et al.
Published: (2022-07-01)

Comparison of lentiviral vector titration methods
by: Debyser Zeger, et al.
Published: (2006-07-01)

Rev-dependent lentiviral expression vector
by: Beddall Margaret H, et al.
Published: (2007-02-01)

Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters
by: Benjamin Vesin, et al.
Published: (2022-12-01)

Improving the quantification of rSIV.F/HN vectors for cystic fibrosis gene therapy using droplet digital PCR
by: Gamlen, T, et al.
Published: (2020)

Intranasal murine pneumonia virus-vectored SARS-CoV-2 vaccine induces mucosal and serum antibodies in macaques
by: Jaclyn A. Kaiser, et al.
Published: (2023-12-01)

Intranasal delivery of replicating mRNA encoding neutralizing antibody against SARS-CoV-2 infection in mice
by: Jia-Qi Li, et al.
Published: (2021-10-01)

Producing and evaluating a novel lentiviral vector for β-thalassaemia gene therapy
by: Bokinni Y, et al.
Published: (2012-07-01)

Lentiviral Vectors as Tools for the Study and Treatment of Glioblastoma
by: Claudia Del Vecchio, et al.
Published: (2019-03-01)

Lentiviral Vectors for Cancer Immunotherapy and Clinical Applications
by: David Escors, et al.
Published: (2013-07-01)

Lentiviral Vectors and Cystic Fibrosis Gene Therapy
by: Massimo Conese, et al.
Published: (2010-01-01)